143 related articles for article (PubMed ID: 8056185)
1. Imbalance of the interleukin 2 system in children with IDDM.
Tomoda T; Kurashige T; Taniguchi T
Diabetologia; 1994 May; 37(5):476-82. PubMed ID: 8056185
[TBL] [Abstract][Full Text] [Related]
2. Immune activation and T cell subset abnormalities in circulation of patients with recently diagnosed type I diabetes mellitus.
al-Kassab AS; Raziuddin S
Clin Exp Immunol; 1990 Aug; 81(2):267-71. PubMed ID: 1696864
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-2 production and interleukin-2 receptor expression in children with newly diagnosed diabetes.
Roncarolo MG; Zoppo M; Bacchetta R; Gabiano C; Sacchetti C; Cerutti F; Tovo PA
Clin Immunol Immunopathol; 1988 Oct; 49(1):53-62. PubMed ID: 3136960
[TBL] [Abstract][Full Text] [Related]
4. Effect of cyclosporin on interleukin 2-related T-lymphocyte parameters in IDDM patients.
Chatenoud L; Feutren G; Nelson DL; Boitard C; Bach JF
Diabetes; 1989 Feb; 38(2):249-56. PubMed ID: 2644144
[TBL] [Abstract][Full Text] [Related]
5. Increased numbers of in vivo activated T cells in patients with recent onset insulin-dependent diabetes mellitus.
Petersen LD; Duinkerken G; Bruining GJ; van Lier RA; de Vries RR; Roep BO
J Autoimmun; 1996 Dec; 9(6):731-7. PubMed ID: 9115575
[TBL] [Abstract][Full Text] [Related]
6. In vitro secretion of interleukin 2 and expression of IL-2 receptor in peripheral blood lymphocytes in high risk of insulin-dependent diabetes mellitus subjects.
Kretowski A; Myśliwiec J; Szelachowska M; Brzozowski C; Pietruczuk M; Kinalska I
Arch Immunol Ther Exp (Warsz); 1999; 47(1):45-9. PubMed ID: 11729828
[TBL] [Abstract][Full Text] [Related]
7. Analysis of T-lymphocyte subsets after phytohemagglutinin stimulation in normal and type 1 diabetic mothers and their infants.
Giordano C; De Maria R; Mattina A; Stassi G; Todaro M; Pugliese A; Galluzzo G; Botta RM; Galluzzo A
Am J Reprod Immunol; 1992 Sep; 28(2):65-70. PubMed ID: 1285852
[TBL] [Abstract][Full Text] [Related]
8. Decreased cell-mediated immunity in patients with non-insulin-dependent diabetes mellitus.
Chang FY; Shaio MF
Diabetes Res Clin Pract; 1995 May; 28(2):137-46. PubMed ID: 7587921
[TBL] [Abstract][Full Text] [Related]
9. Defective expression of the apoptosis-inducing CD95 (Fas/APO-1) molecule on T and B cells in IDDM.
Giordano C; De Maria R; Stassi G; Todaro M; Richiusa P; Giordano M; Testi R; Galluzzo A
Diabetologia; 1995 Dec; 38(12):1449-54. PubMed ID: 8786019
[TBL] [Abstract][Full Text] [Related]
10. Increased CD69 and human leukocyte antigen-DR expression on T lymphocytes in insulin-dependent diabetes mellitus of long standing.
Gessl A; Waldhäusl W
J Clin Endocrinol Metab; 1998 Jun; 83(6):2204-9. PubMed ID: 9626161
[TBL] [Abstract][Full Text] [Related]
11. Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes.
Brusko TM; Wasserfall CH; Clare-Salzler MJ; Schatz DA; Atkinson MA
Diabetes; 2005 May; 54(5):1407-14. PubMed ID: 15855327
[TBL] [Abstract][Full Text] [Related]
12. The majority of the activated T cells in the blood of insulin-dependent diabetes mellitus (IDDM) patients are CD4+.
De Berardinis P; Londei M; Kahan M; Balsano F; Kontiainen S; Gale EA; Bottazzo GF; Feldmann M
Clin Exp Immunol; 1988 Aug; 73(2):255-9. PubMed ID: 2972427
[TBL] [Abstract][Full Text] [Related]
13. Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus.
Berman MA; Sandborg CI; Wang Z; Imfeld KL; Zaldivar F; Dadufalza V; Buckingham BA
J Immunol; 1996 Nov; 157(10):4690-6. PubMed ID: 8906850
[TBL] [Abstract][Full Text] [Related]
14. Increase in simultaneous coexpression of naive and memory lymphocyte markers at diagnosis of IDDM.
Smerdon RA; Peakman M; Hussain MJ; Alviggi L; Watkins PJ; Leslie RD; Vergani D
Diabetes; 1993 Jan; 42(1):127-33. PubMed ID: 8420810
[TBL] [Abstract][Full Text] [Related]
15. Constitutive impaired TCR/CD3-mediated activation of T cells in IDDM patients co-exist with normal co-stimulation pathways.
Nervi S; Atlan-Gepner C; Fossat C; Vialettes B
J Autoimmun; 1999 Sep; 13(2):247-55. PubMed ID: 10479393
[TBL] [Abstract][Full Text] [Related]
16. Abnormalities of CD4+ T lymphocyte proliferative responses from patients with recently diagnosed insulin-dependent diabetes mellitus.
al-Kassab AS; Raziuddin S
Diabetes Res Clin Pract; 1990; 10(1):45-9. PubMed ID: 2123429
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte subset abnormalities, autoantibodies and their relationship with HLA DR types in children with type 1 (insulin-dependent) diabetes and their first degree relatives.
Peakman M; Warnock T; Vats A; McNab GL; Underhill J; Donaldson PT; Vergani D
Diabetologia; 1994 Feb; 37(2):155-65. PubMed ID: 8163049
[TBL] [Abstract][Full Text] [Related]
18. Age-related changes in intracellular TH1/TH2 cytokine production, immunoproliferative T lymphocyte response and natural killer cell activity in newborns, children and adults.
Gasparoni A; Ciardelli L; Avanzini A; Castellazzi AM; Carini R; Rondini G; Chirico G
Biol Neonate; 2003; 84(4):297-303. PubMed ID: 14593240
[TBL] [Abstract][Full Text] [Related]
19. Cell-mediated immunity and biological response modifiers in insulin-dependent diabetes mellitus complicated by end-stage renal disease.
Attallah AM; Abdelghaffar H; Fawzy A; Alghraoui F; Alijani MR; Mahmoud LA; Ghoneim MA; Helfrich GB
Int Arch Allergy Appl Immunol; 1987; 83(3):278-83. PubMed ID: 3110074
[TBL] [Abstract][Full Text] [Related]
20. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients.
Endl J; Otto H; Jung G; Dreisbusch B; Donie F; Stahl P; Elbracht R; Schmitz G; Meinl E; Hummel M; Ziegler AG; Wank R; Schendel DJ
J Clin Invest; 1997 May; 99(10):2405-15. PubMed ID: 9153283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
